The Food and Drugs Authority (FDA) has expressed its readiness to undergo audits by both local and international bodies to ...

The FDA extended the Prescription Drug User Fee Act date for the biologics license application seeking approval of zenocutuzumab for NRG1-positive lung and pancreatic cancer.

Shares of U.S. pharmaceutical companies, especially vaccine makers, fell on Friday on concerns over the changes Kennedy could ...

RFK Jr has vowed to shake up the FDA, but the CBER head said support for the agency’s public health mission continues.

At least 68 people have fallen ill in the outbreak believed to be linked to cucumbers sold in the United States and Canada, ...

Ron DeSantis speaks at a news conference at a pharmaceutical warehouse run by LifeScience Logistics on May ... Florida Gov. Ron DeSantis hailed the FDA’s approval of his plan in January, calling it a ...

But the basic idea behind his effort to “Make America Healthy Again” is correct: America is not healthy, and our current ...

SMi Group Reports: Following the FDA’s release of a ... [centerforbiosimilars.com] Also in recent news were statements made by the chair of this year’s two-day conference; Richard DiCicco ...

Following the initial detection, the agency sought to identify the specific raw ingredient in the product contaminated with Sudan dye, a red synthetic dye that is banned in Taiwan for use in ...

FDA Commissioner Califf anticipates changes ... s commissioner under the Obama administration beginning in 2016. At a conference hosted by the Friends of Cancer Research, Califf acknowledged ...

Four keys to victory for Southern in the 51st annual Bayou Classic against Grambling at 1 p.m. Saturday at the Caesars ...

The FDA has extended its review of zenocutuzumab's in NRG1+ NSCLC and PDAC to February 2025, with efficacy and safety data from the eNRGy trial supporting the application. The FDA has extended the ...